ALG8 is the endoplasmic reticulum (ER)-lumenal, Dol-P-Glc-dependent alpha-1,3-glucosyltransferase (EC 2.4.1.265) that catalyzes the second of the three glucosylation steps in assembly of the dolichol-linked oligosaccharide (LLO), the Glc3Man9GlcNAc2 glycan precursor used for protein N-linked glycosylation. Acting on the lumenal face of the ER membrane, it transfers a glucose residue from dolichyl-phosphate-glucose (Dol-P-Glc, not UDP-Glc) onto the lipid-linked intermediate Glc1Man9GlcNAc2-PP-dolichol to give Glc2Man9GlcNAc2-PP-dolichol, the substrate for the following enzyme ALG10. ALG8 is a polytopic (multi-pass) ER membrane protein of the ALG6/ALG8 glucosyltransferase family (CAZy GT57). It functions in the dolichol-linked oligosaccharide biosynthetic process and, downstream, in protein N-linked glycosylation. Loss-of-function variants cause the autosomal recessive multisystem congenital disorder of glycosylation type Ih (ALG8-CDG / CDG-Ih), characterized by hypoglycosylation of serum glycoproteins; ALG8 variants are also associated with isolated polycystic liver disease.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005789
endoplasmic reticulum membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ALG8 is an ER membrane enzyme; the phylogenetically inferred ER membrane localization is fully consistent with experimental and UniProt evidence. ALG8 is a multi-pass ER membrane protein that acts on the lumenal side of the ER membrane during LLO assembly. Correct and core.
Reason: IBA localization to the ER membrane matches the UniProt-curated subcellular location and the enzyme's role in ER-lumenal LLO assembly.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
file:human/ALG8/ALG8-uniprot.txt
Multi-pass membrane protein
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ALG8 adds the second glucose to the growing lipid-linked oligosaccharide (LLO), a defining step of dolichol-linked oligosaccharide biosynthesis. This is the core biological process for the gene and is supported by experimental (IMP) evidence in humans as well as the phylogenetic inference. Correct and core.
Reason: The gene's characterized enzymatic step (adding glucose to Glc1Man9GlcNAc2-PP-Dol) is part of dolichol-linked oligosaccharide biosynthesis; the IBA agrees with experimental annotations from PubMed:12480927 and PubMed:15235028.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
adds the second glucose residue from dolichyl phosphate glucose
|
|
GO:0042283
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: This is the precise, correct molecular function of ALG8: the Dol-P-Glc-dependent alpha-1,3-glucosyltransferase (EC 2.4.1.265) that adds the second glucose from Dol-P-Glc onto Glc1Man9GlcNAc2-PP-Dol to give Glc2Man9GlcNAc2-PP-Dol. The phylogenetic inference agrees with human experimental evidence and is the core enzymatic activity.
Reason: This IBA term is the exact characterized activity of ALG8 and matches the UniProt catalytic-activity annotation and the experimental IMP annotations. Core molecular function.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
adds the second glucose residue from dolichyl phosphate glucose
PMID:12480927
which catalyzes this reaction
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: IEA localization to the ER membrane derived from the UniProt Swiss-Prot subcellular location mapping. This agrees with the experimentally supported (PubMed:15235028) UniProt subcellular location annotation. Correct.
Reason: The mapping reproduces the curated ER membrane location, which is experimentally grounded.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0016758
hexosyltransferase activity
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: InterPro2GO mapping (IPR004856, ALG6/ALG8 glucosyltransferase family) to the generic parent term hexosyltransferase activity. This is correct but much more general than ALG8's characterized activity (GO:0042283, dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity), which is already annotated.
Reason: Not wrong, but too general given the specific EC 2.4.1.265 activity is established. Replace with the specific glucosyltransferase term already supported by experimental and phylogenetic evidence.
Proposed replacements:
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
Belongs to the ALG6/ALG8 glucosyltransferase family
|
|
GO:0042283
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (RHEA:31307 / EC:2.4.1.265) assignment of the precise enzymatic activity. This matches the UniProt catalytic activity annotation and the experimental evidence. Correct and core.
Reason: RHEA/EC-based IEA reproduces the exact experimentally established activity (EC 2.4.1.265), consistent with the IBA and IMP annotations to the same term.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
adds the second glucose residue from dolichyl phosphate glucose
|
|
GO:0005515
protein binding
|
IPI
PMID:25910212 Widespread macromolecular interaction perturbations in human... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from a large-scale interactome/edgotyping study (Sahni et al. 2015). The recorded interactor is CREB3 (UniProtKB:O43889-2). This uninformative MF term does not describe ALG8's actual glucosyltransferase function and the interaction has no established biological role for ALG8.
Reason: "Protein binding" (GO:0005515) is uninformative and comes from a high-throughput screen; it is retained but flagged as over-annotation rather than removed, per curation policy for experimental IPIs.
Supporting Evidence:
PMID:25910212
two-thirds of disease-associated alleles perturb protein-protein
file:human/ALG8/ALG8-uniprot.txt
Q9BVK2; O43889-2: CREB3; NbExp=3; IntAct=EBI-3921603, EBI-625022;
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from the HuRI human binary (Y2H) interactome map (Luck et al. 2020). Recorded interactors for ALG8 include CYB5R3 (P00387), CLRN1 (P58418), BIK (Q13323), FAM209A (Q5JX71), MFSD6 (Q6ZSS7), GPX8 (Q8TED1), CREB3L1 (Q96BA8) and SAR1A (Q9NR31). These are largely other ER/membrane proteins; none establishes a specific molecular function for ALG8, and the term itself is uninformative.
Reason: "Protein binding" is uninformative and derives from a proteome-scale Y2H screen; retained but flagged as over-annotation per policy for experimental IPIs.
Supporting Evidence:
PMID:32296183
reference interactome map of human binary protein interactions
file:human/ALG8/ALG8-uniprot.txt
Q9BVK2; P00387: CYB5R3; NbExp=3; IntAct=EBI-3921603, EBI-1046040;
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" IPI from the BioPlex 3.0 affinity-purification mass-spectrometry interactome (Huttlin et al. 2021). The recorded interactor is ALG6 (UniProtKB:Q9Y672), the alpha-1,3-glucosyltransferase that acts immediately before ALG8 in LLO assembly; a physical association between these two sequential ER-membrane glucosyltransferases is biologically plausible, but "protein binding" is still an uninformative MF term.
Reason: Although the ALG6 interactor is pathway-relevant, GO:0005515 conveys no specific molecular function; retained but flagged as over-annotation per policy for experimental IPIs.
Supporting Evidence:
PMID:33961781
affinity-purification
file:human/ALG8/ALG8-uniprot.txt
Q9BVK2; Q9Y672: ALG6; NbExp=2; IntAct=EBI-3921603, EBI-11337956;
|
|
GO:0006487
protein N-linked glycosylation
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA transfer from mouse ortholog (Q6P8H8) via Ensembl Compara to protein N-linked glycosylation. ALG8 builds the LLO glycan precursor that is transferred to nascent proteins, so involvement in N-linked glycosylation is correct, though it is one step removed from the direct enzymatic reaction (LLO assembly).
Reason: ALG8's role in assembling the Glc3Man9GlcNAc2 precursor makes it a genuine participant in protein N-linked glycosylation; consistent with experimental IMP and ISS annotations to the same term.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
the glycan precursors employed in
CC protein asparagine (N)-glycosylation
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
TAS
Reactome:R-HSA-446193 |
ACCEPT |
Summary: Reactome TAS placing ALG8 in the LLO (dolichol lipid-linked oligosaccharide) biosynthesis and transfer pathway. This is the core biological process for ALG8 and is corroborated by experimental IMP annotations. Correct and core.
Reason: Reactome authored the LLO biosynthesis pathway including the ALG8-catalyzed second glucose addition; consistent with IBA/IMP annotations to the same term.
Supporting Evidence:
Reactome:R-HSA-446189
The second glucose (supplied from the donor dolichol-phosphate-glucose) is added to the N-glycan precursor, mediated by ALG8
|
|
GO:0098553
lumenal side of endoplasmic reticulum membrane
|
IC
PMID:15235028 Clinical and molecular features of three patients with conge... |
ACCEPT |
Summary: Inferred by curator (IC) that ALG8 acts on the lumenal side of the ER membrane. The glucose additions occur after the LLO intermediate is flipped to the ER lumen, and ALG8 uses lumenal Dol-P-Glc; UniProt states the assembly "finishes in its lumen" and that ALG8 acts "In the lumen of the endoplasmic reticulum". This precise topological localization is correct and biologically informative.
Reason: The lumenal orientation of the ALG8-catalyzed glucosylation step is well established; the IC annotation captures the correct membrane topology and is consistent with UniProt.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
adds the second glucose residue from dolichyl phosphate glucose
PMID:15235028
(CDG-Ih) (ALG8 deficiency)
|
|
GO:0005789
endoplasmic reticulum membrane
|
IGI
PMID:15235028 Clinical and molecular features of three patients with conge... |
ACCEPT |
Summary: Experimental (IGI, with yeast Alg8 P40351) support that human ALG8 is active in the ER membrane, from the CDG-Ih characterization study (Schollen et al. 2004). ALG8 is a multi-pass ER membrane enzyme; this is the core cellular location. Correct and core.
Reason: Genetic-interaction/complementation evidence (with the yeast ortholog) supports ER membrane activity; consistent with UniProt subcellular location. Curator read the full text of this abstract-only paper.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
PMID:15235028
(CDG-Ih) (ALG8 deficiency)
|
|
GO:0006487
protein N-linked glycosylation
|
IMP
PMID:15235028 Clinical and molecular features of three patients with conge... |
ACCEPT |
Summary: Experimental (IMP) evidence that ALG8 loss impairs protein N-linked glycosylation, from CDG-Ih patients with ALG8 deficiency who show under-glycosylated serum glycoproteins (Schollen et al. 2004). ALG8 builds the LLO precursor transferred to nascent proteins. Correct.
Reason: Patient-derived loss-of-function characterization demonstrates ALG8's requirement for normal N-glycosylation; the curator read the full text.
Supporting Evidence:
PMID:15235028
(CDG-Ih) (ALG8 deficiency)
file:human/ALG8/ALG8-uniprot.txt
the glycan precursors employed in
CC protein asparagine (N)-glycosylation
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IMP
PMID:12480927 A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolich... |
ACCEPT |
Summary: Experimental (IMP) evidence from the founding CDG-Ih study (Chantret et al. 2003): patient fibroblasts with reduced ALG8 mRNA accumulate Man9GlcNAc2-PP-dolichol (and, with castanospermine, Glc1Man9GlcNAc2-PP-Dol), indicating inefficient addition of the second glucose to the LLO, and are rescued by wild-type ALG8 cDNA. This is the core biological process.
Reason: Loss-of-ALG8 blocks LLO maturation with accumulation of the immediate substrate, directly demonstrating involvement in dolichol-linked oligosaccharide biosynthesis. Core process.
Supporting Evidence:
PMID:12480927
suggesting inefficient addition of the second glucose residue onto
PMID:12480927
biosynthesis of the dolichyl-linked oligosaccharide
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IMP
PMID:15235028 Clinical and molecular features of three patients with conge... |
ACCEPT |
Summary: Experimental (IMP) evidence from a second CDG-Ih cohort (Schollen et al. 2004): ALG8-deficient patients with characterized loss-of-function variants (T47P, G275D) show impaired LLO glucosylation. Confirms ALG8's role in dolichol-linked oligosaccharide biosynthesis. Core process.
Reason: Independent patient/variant characterization corroborates ALG8's requirement for LLO biosynthesis; curator read the full text.
Supporting Evidence:
PMID:15235028
(CDG-Ih) (ALG8 deficiency)
file:human/ALG8/ALG8-uniprot.txt
adds the second glucose residue from dolichyl phosphate glucose
|
|
GO:0042283
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
|
IMP
PMID:12480927 A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolich... |
ACCEPT |
Summary: Experimental (IMP) support for ALG8's Dol-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl alpha-1,3-glucosyltransferase activity: Chantret et al. 2003 identify ALG8 as the enzyme catalyzing addition of the second glucose to the LLO, with loss of function causing substrate accumulation and rescue by wild-type cDNA. Core molecular function.
Reason: Directly demonstrates the characterized enzymatic activity (EC 2.4.1.265) via loss-of-function and complementation. Core MF.
Supporting Evidence:
PMID:12480927
which catalyzes this reaction
PMID:12480927
suggesting inefficient addition of the second glucose residue onto
|
|
GO:0042283
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
|
IMP
PMID:15235028 Clinical and molecular features of three patients with conge... |
ACCEPT |
Summary: Experimental (IMP) support for ALG8's glucosyltransferase activity from Schollen et al. 2004; UniProt records that the CDG1H variants T47P and G275D show "decreased dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity", directly implicating ALG8 in this reaction. Core molecular function.
Reason: Variant characterization demonstrates reduced enzymatic activity, an experimental measure of the annotated MF; curator read full text.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
decreased dolichyl pyrophosphate
FT Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
PMID:15235028
(CDG-Ih) (ALG8 deficiency)
|
|
GO:0004583
dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity
|
TAS
Reactome:R-HSA-446189 |
MODIFY |
Summary: Reactome TAS to GO:0004583, the parent term for Dol-P-Glc-dependent alpha-glucosyltransferase activity. This is correct but less precise than the specific EC 2.4.1.265 term GO:0042283 that is already annotated experimentally. It captures the Dol-P-Glc donor specificity, which is biologically important.
Reason: The essence (Dol-P-Glc-dependent alpha-glucosyltransferase) is correct but too general; the specific activity term GO:0042283 (the exact reaction ALG8 catalyzes) is preferable.
Proposed replacements:
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
Supporting Evidence:
Reactome:R-HSA-446189
The second glucose (supplied from the donor dolichol-phosphate-glucose) is added to the N-glycan precursor, mediated by ALG8
|
|
GO:0004583
dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity
|
TAS
Reactome:R-HSA-4724330 |
MODIFY |
Summary: Reactome TAS (from the "Defective ALG8 causes CDG-1h" disease reaction) to the parent term GO:0004583. Same activity as the sibling Reactome annotation; correct but less precise than the specific EC 2.4.1.265 term.
Reason: Correct Dol-P-Glc-dependent glucosyltransferase activity but too general; prefer the specific GO:0042283 term.
Proposed replacements:
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
Supporting Evidence:
Reactome:R-HSA-4724330
normally adds the second glucose moiety to the lipid-linked oligosaccharide precursor (LLO aka N-glycan precursor) which is required for subsequent N-glycosylation of proteins
|
|
GO:0006487
protein N-linked glycosylation
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS transfer (from mouse ortholog Q6P8H8) to protein N-linked glycosylation. Consistent with the experimental IMP and the IEA (Ensembl) annotations to the same term; ALG8 assembles the glycan precursor used in N-glycosylation. Correct.
Reason: Sequence-similarity inference to a well-supported process; redundant with but consistent with the human experimental annotation.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
the glycan precursors employed in
CC protein asparagine (N)-glycosylation
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-4724330 |
ACCEPT |
Summary: Reactome TAS ER membrane localization, consistent with the experimental and UniProt-curated ER membrane location. Correct and core.
Reason: Reproduces the well-supported ER membrane localization of this multi-pass membrane enzyme.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-446189 |
ACCEPT |
Summary: Reactome TAS ER membrane localization (duplicate of the sibling Reactome CC annotation), consistent with experimental and UniProt evidence. Correct and core.
Reason: Reproduces the well-supported ER membrane localization; duplicates are acceptable across evidence sources.
Supporting Evidence:
file:human/ALG8/ALG8-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0006487
protein N-linked glycosylation
|
IMP
PMID:12480927 A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolich... |
ACCEPT |
Summary: Experimental (IMP) evidence that ALG8 deficiency (CDG-Ih) impairs protein N-linked glycosylation (Chantret et al. 2003), which defined this new subtype of type I congenital disorders of glycosylation — disorders caused by defective assembly of the dolichyl-linked oligosaccharide required for protein glycosylation. Correct.
Reason: Patient loss-of-function evidence links ALG8 to N-glycosylation via defective LLO assembly; consistent with other N-glycosylation annotations.
Supporting Evidence:
PMID:12480927
the underlying cause of this new CDG I
PMID:12480927
biosynthesis of the dolichyl-linked oligosaccharide
|
id: Q9BVK2
gene_symbol: ALG8
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
ALG8 is the endoplasmic reticulum (ER)-lumenal, Dol-P-Glc-dependent
alpha-1,3-glucosyltransferase (EC 2.4.1.265) that catalyzes the second of the
three glucosylation steps in assembly of the dolichol-linked oligosaccharide
(LLO), the Glc3Man9GlcNAc2 glycan precursor used for protein N-linked
glycosylation. Acting on the lumenal face of the ER membrane, it transfers a
glucose residue from dolichyl-phosphate-glucose (Dol-P-Glc, not UDP-Glc) onto
the lipid-linked intermediate Glc1Man9GlcNAc2-PP-dolichol to give
Glc2Man9GlcNAc2-PP-dolichol, the substrate for the following enzyme ALG10.
ALG8 is a polytopic (multi-pass) ER membrane protein of the ALG6/ALG8
glucosyltransferase family (CAZy GT57). It functions in the dolichol-linked
oligosaccharide biosynthetic process and, downstream, in protein N-linked
glycosylation. Loss-of-function variants cause the autosomal recessive
multisystem congenital disorder of glycosylation type Ih (ALG8-CDG / CDG-Ih),
characterized by hypoglycosylation of serum glycoproteins; ALG8 variants are
also associated with isolated polycystic liver disease.
alternative_products:
- name: '1'
id: Q9BVK2-1
- name: '2'
id: Q9BVK2-2
sequence_note: VSP_046291
existing_annotations:
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
ALG8 is an ER membrane enzyme; the phylogenetically inferred ER membrane
localization is fully consistent with experimental and UniProt evidence.
ALG8 is a multi-pass ER membrane protein that acts on the lumenal side of
the ER membrane during LLO assembly. Correct and core.
action: ACCEPT
reason: >-
IBA localization to the ER membrane matches the UniProt-curated
subcellular location and the enzyme's role in ER-lumenal LLO assembly.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum membrane"
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "Multi-pass membrane protein"
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
ALG8 adds the second glucose to the growing lipid-linked oligosaccharide
(LLO), a defining step of dolichol-linked oligosaccharide biosynthesis.
This is the core biological process for the gene and is supported by
experimental (IMP) evidence in humans as well as the phylogenetic
inference. Correct and core.
action: ACCEPT
reason: >-
The gene's characterized enzymatic step (adding glucose to
Glc1Man9GlcNAc2-PP-Dol) is part of dolichol-linked oligosaccharide
biosynthesis; the IBA agrees with experimental annotations from
PubMed:12480927 and PubMed:15235028.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "adds the second glucose residue from dolichyl phosphate glucose"
- term:
id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
This is the precise, correct molecular function of ALG8: the
Dol-P-Glc-dependent alpha-1,3-glucosyltransferase (EC 2.4.1.265) that adds
the second glucose from Dol-P-Glc onto Glc1Man9GlcNAc2-PP-Dol to give
Glc2Man9GlcNAc2-PP-Dol. The phylogenetic inference agrees with human
experimental evidence and is the core enzymatic activity.
action: ACCEPT
reason: >-
This IBA term is the exact characterized activity of ALG8 and matches the
UniProt catalytic-activity annotation and the experimental IMP
annotations. Core molecular function.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "adds the second glucose residue from dolichyl phosphate glucose"
- reference_id: PMID:12480927
supporting_text: "which catalyzes this reaction"
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
IEA localization to the ER membrane derived from the UniProt
Swiss-Prot subcellular location mapping. This agrees with the
experimentally supported (PubMed:15235028) UniProt subcellular location
annotation. Correct.
action: ACCEPT
reason: >-
The mapping reproduces the curated ER membrane location, which is
experimentally grounded.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum membrane"
- term:
id: GO:0016758
label: hexosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro2GO mapping (IPR004856, ALG6/ALG8 glucosyltransferase family) to
the generic parent term hexosyltransferase activity. This is correct but
much more general than ALG8's characterized activity (GO:0042283,
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase
activity), which is already annotated.
action: MODIFY
reason: >-
Not wrong, but too general given the specific EC 2.4.1.265 activity is
established. Replace with the specific glucosyltransferase term already
supported by experimental and phylogenetic evidence.
proposed_replacement_terms:
- id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "Belongs to the ALG6/ALG8 glucosyltransferase family"
- term:
id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Automated (RHEA:31307 / EC:2.4.1.265) assignment of the precise enzymatic
activity. This matches the UniProt catalytic activity annotation and the
experimental evidence. Correct and core.
action: ACCEPT
reason: >-
RHEA/EC-based IEA reproduces the exact experimentally established activity
(EC 2.4.1.265), consistent with the IBA and IMP annotations to the same
term.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "adds the second glucose residue from dolichyl phosphate glucose"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25910212
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from a large-scale interactome/edgotyping study
(Sahni et al. 2015). The recorded interactor is CREB3 (UniProtKB:O43889-2).
This uninformative MF term does not describe ALG8's actual glucosyltransferase
function and the interaction has no established biological role for ALG8.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" (GO:0005515) is uninformative and comes from a
high-throughput screen; it is retained but flagged as over-annotation
rather than removed, per curation policy for experimental IPIs.
supported_by:
- reference_id: PMID:25910212
supporting_text: "two-thirds of disease-associated alleles perturb protein-protein"
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "Q9BVK2; O43889-2: CREB3; NbExp=3; IntAct=EBI-3921603, EBI-625022;"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from the HuRI human binary (Y2H) interactome
map (Luck et al. 2020). Recorded interactors for ALG8 include CYB5R3
(P00387), CLRN1 (P58418), BIK (Q13323), FAM209A (Q5JX71), MFSD6 (Q6ZSS7),
GPX8 (Q8TED1), CREB3L1 (Q96BA8) and SAR1A (Q9NR31). These are largely
other ER/membrane proteins; none establishes a specific molecular
function for ALG8, and the term itself is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative and derives from a proteome-scale Y2H
screen; retained but flagged as over-annotation per policy for
experimental IPIs.
supported_by:
- reference_id: PMID:32296183
supporting_text: "reference interactome map of human binary protein interactions"
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "Q9BVK2; P00387: CYB5R3; NbExp=3; IntAct=EBI-3921603, EBI-1046040;"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
Bare "protein binding" IPI from the BioPlex 3.0 affinity-purification
mass-spectrometry interactome (Huttlin et al. 2021). The recorded
interactor is ALG6 (UniProtKB:Q9Y672), the alpha-1,3-glucosyltransferase
that acts immediately before ALG8 in LLO assembly; a physical association
between these two sequential ER-membrane glucosyltransferases is
biologically plausible, but "protein binding" is still an uninformative
MF term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Although the ALG6 interactor is pathway-relevant, GO:0005515 conveys no
specific molecular function; retained but flagged as over-annotation per
policy for experimental IPIs.
supported_by:
- reference_id: PMID:33961781
supporting_text: "affinity-purification"
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "Q9BVK2; Q9Y672: ALG6; NbExp=2; IntAct=EBI-3921603, EBI-11337956;"
- term:
id: GO:0006487
label: protein N-linked glycosylation
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
IEA transfer from mouse ortholog (Q6P8H8) via Ensembl Compara to protein
N-linked glycosylation. ALG8 builds the LLO glycan precursor that is
transferred to nascent proteins, so involvement in N-linked glycosylation
is correct, though it is one step removed from the direct enzymatic
reaction (LLO assembly).
action: ACCEPT
reason: >-
ALG8's role in assembling the Glc3Man9GlcNAc2 precursor makes it a
genuine participant in protein N-linked glycosylation; consistent with
experimental IMP and ISS annotations to the same term.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "the glycan precursors employed in\nCC protein asparagine (N)-glycosylation"
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-446193
qualifier: involved_in
review:
summary: >-
Reactome TAS placing ALG8 in the LLO (dolichol lipid-linked
oligosaccharide) biosynthesis and transfer pathway. This is the core
biological process for ALG8 and is corroborated by experimental IMP
annotations. Correct and core.
action: ACCEPT
reason: >-
Reactome authored the LLO biosynthesis pathway including the ALG8-catalyzed
second glucose addition; consistent with IBA/IMP annotations to the same
term.
supported_by:
- reference_id: Reactome:R-HSA-446189
supporting_text: "The second glucose (supplied from the donor dolichol-phosphate-glucose) is added to the N-glycan precursor, mediated by ALG8"
- term:
id: GO:0098553
label: lumenal side of endoplasmic reticulum membrane
evidence_type: IC
original_reference_id: PMID:15235028
qualifier: is_active_in
review:
summary: >-
Inferred by curator (IC) that ALG8 acts on the lumenal side of the ER
membrane. The glucose additions occur after the LLO intermediate is
flipped to the ER lumen, and ALG8 uses lumenal Dol-P-Glc; UniProt states
the assembly "finishes in its lumen" and that ALG8 acts "In the lumen of
the endoplasmic reticulum". This precise topological localization is
correct and biologically informative.
action: ACCEPT
reason: >-
The lumenal orientation of the ALG8-catalyzed glucosylation step is
well established; the IC annotation captures the correct membrane
topology and is consistent with UniProt.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "adds the second glucose residue from dolichyl phosphate glucose"
- reference_id: PMID:15235028
supporting_text: "(CDG-Ih) (ALG8 deficiency)"
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IGI
original_reference_id: PMID:15235028
qualifier: is_active_in
review:
summary: >-
Experimental (IGI, with yeast Alg8 P40351) support that human ALG8 is
active in the ER membrane, from the CDG-Ih characterization study
(Schollen et al. 2004). ALG8 is a multi-pass ER membrane enzyme; this is
the core cellular location. Correct and core.
action: ACCEPT
reason: >-
Genetic-interaction/complementation evidence (with the yeast ortholog)
supports ER membrane activity; consistent with UniProt subcellular
location. Curator read the full text of this abstract-only paper.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum membrane"
- reference_id: PMID:15235028
supporting_text: "(CDG-Ih) (ALG8 deficiency)"
- term:
id: GO:0006487
label: protein N-linked glycosylation
evidence_type: IMP
original_reference_id: PMID:15235028
qualifier: involved_in
review:
summary: >-
Experimental (IMP) evidence that ALG8 loss impairs protein N-linked
glycosylation, from CDG-Ih patients with ALG8 deficiency who show
under-glycosylated serum glycoproteins (Schollen et al. 2004). ALG8 builds
the LLO precursor transferred to nascent proteins. Correct.
action: ACCEPT
reason: >-
Patient-derived loss-of-function characterization demonstrates ALG8's
requirement for normal N-glycosylation; the curator read the full text.
supported_by:
- reference_id: PMID:15235028
supporting_text: "(CDG-Ih) (ALG8 deficiency)"
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "the glycan precursors employed in\nCC protein asparagine (N)-glycosylation"
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IMP
original_reference_id: PMID:12480927
qualifier: involved_in
review:
summary: >-
Experimental (IMP) evidence from the founding CDG-Ih study (Chantret et
al. 2003): patient fibroblasts with reduced ALG8 mRNA accumulate
Man9GlcNAc2-PP-dolichol (and, with castanospermine, Glc1Man9GlcNAc2-PP-Dol),
indicating inefficient addition of the second glucose to the LLO, and are
rescued by wild-type ALG8 cDNA. This is the core biological process.
action: ACCEPT
reason: >-
Loss-of-ALG8 blocks LLO maturation with accumulation of the immediate
substrate, directly demonstrating involvement in dolichol-linked
oligosaccharide biosynthesis. Core process.
supported_by:
- reference_id: PMID:12480927
supporting_text: "suggesting inefficient addition of the second glucose residue onto"
- reference_id: PMID:12480927
supporting_text: "biosynthesis of the dolichyl-linked oligosaccharide"
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IMP
original_reference_id: PMID:15235028
qualifier: involved_in
review:
summary: >-
Experimental (IMP) evidence from a second CDG-Ih cohort (Schollen et al.
2004): ALG8-deficient patients with characterized loss-of-function
variants (T47P, G275D) show impaired LLO glucosylation. Confirms ALG8's
role in dolichol-linked oligosaccharide biosynthesis. Core process.
action: ACCEPT
reason: >-
Independent patient/variant characterization corroborates ALG8's
requirement for LLO biosynthesis; curator read the full text.
supported_by:
- reference_id: PMID:15235028
supporting_text: "(CDG-Ih) (ALG8 deficiency)"
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "adds the second glucose residue from dolichyl phosphate glucose"
- term:
id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
evidence_type: IMP
original_reference_id: PMID:12480927
qualifier: enables
review:
summary: >-
Experimental (IMP) support for ALG8's Dol-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl
alpha-1,3-glucosyltransferase activity: Chantret et al. 2003 identify ALG8
as the enzyme catalyzing addition of the second glucose to the LLO, with
loss of function causing substrate accumulation and rescue by wild-type
cDNA. Core molecular function.
action: ACCEPT
reason: >-
Directly demonstrates the characterized enzymatic activity (EC 2.4.1.265)
via loss-of-function and complementation. Core MF.
supported_by:
- reference_id: PMID:12480927
supporting_text: "which catalyzes this reaction"
- reference_id: PMID:12480927
supporting_text: "suggesting inefficient addition of the second glucose residue onto"
- term:
id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
evidence_type: IMP
original_reference_id: PMID:15235028
qualifier: enables
review:
summary: >-
Experimental (IMP) support for ALG8's glucosyltransferase activity from
Schollen et al. 2004; UniProt records that the CDG1H variants T47P and
G275D show "decreased dolichyl pyrophosphate Glc1Man9GlcNAc2
alpha-1,3-glucosyltransferase activity", directly implicating ALG8 in this
reaction. Core molecular function.
action: ACCEPT
reason: >-
Variant characterization demonstrates reduced enzymatic activity, an
experimental measure of the annotated MF; curator read full text.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "decreased dolichyl pyrophosphate\nFT Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity"
- reference_id: PMID:15235028
supporting_text: "(CDG-Ih) (ALG8 deficiency)"
- term:
id: GO:0004583
label: dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-446189
qualifier: enables
review:
summary: >-
Reactome TAS to GO:0004583, the parent term for Dol-P-Glc-dependent
alpha-glucosyltransferase activity. This is correct but less precise than
the specific EC 2.4.1.265 term GO:0042283 that is already annotated
experimentally. It captures the Dol-P-Glc donor specificity, which is
biologically important.
action: MODIFY
reason: >-
The essence (Dol-P-Glc-dependent alpha-glucosyltransferase) is correct but
too general; the specific activity term GO:0042283 (the exact reaction
ALG8 catalyzes) is preferable.
proposed_replacement_terms:
- id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
supported_by:
- reference_id: Reactome:R-HSA-446189
supporting_text: "The second glucose (supplied from the donor dolichol-phosphate-glucose) is added to the N-glycan precursor, mediated by ALG8"
- term:
id: GO:0004583
label: dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-4724330
qualifier: enables
review:
summary: >-
Reactome TAS (from the "Defective ALG8 causes CDG-1h" disease reaction) to
the parent term GO:0004583. Same activity as the sibling Reactome
annotation; correct but less precise than the specific EC 2.4.1.265 term.
action: MODIFY
reason: >-
Correct Dol-P-Glc-dependent glucosyltransferase activity but too general;
prefer the specific GO:0042283 term.
proposed_replacement_terms:
- id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
supported_by:
- reference_id: Reactome:R-HSA-4724330
supporting_text: "normally adds the second glucose moiety to the lipid-linked oligosaccharide precursor (LLO aka N-glycan precursor) which is required for subsequent N-glycosylation of proteins"
- term:
id: GO:0006487
label: protein N-linked glycosylation
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
ISS transfer (from mouse ortholog Q6P8H8) to protein N-linked
glycosylation. Consistent with the experimental IMP and the IEA (Ensembl)
annotations to the same term; ALG8 assembles the glycan precursor used in
N-glycosylation. Correct.
action: ACCEPT
reason: >-
Sequence-similarity inference to a well-supported process; redundant with
but consistent with the human experimental annotation.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "the glycan precursors employed in\nCC protein asparagine (N)-glycosylation"
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-4724330
qualifier: located_in
review:
summary: >-
Reactome TAS ER membrane localization, consistent with the experimental
and UniProt-curated ER membrane location. Correct and core.
action: ACCEPT
reason: >-
Reproduces the well-supported ER membrane localization of this multi-pass
membrane enzyme.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum membrane"
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-446189
qualifier: located_in
review:
summary: >-
Reactome TAS ER membrane localization (duplicate of the sibling Reactome
CC annotation), consistent with experimental and UniProt evidence.
Correct and core.
action: ACCEPT
reason: >-
Reproduces the well-supported ER membrane localization; duplicates are
acceptable across evidence sources.
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum membrane"
- term:
id: GO:0006487
label: protein N-linked glycosylation
evidence_type: IMP
original_reference_id: PMID:12480927
qualifier: involved_in
review:
summary: >-
Experimental (IMP) evidence that ALG8 deficiency (CDG-Ih) impairs protein
N-linked glycosylation (Chantret et al. 2003), which defined this new
subtype of type I congenital disorders of glycosylation — disorders caused
by defective assembly of the dolichyl-linked oligosaccharide required for
protein glycosylation. Correct.
action: ACCEPT
reason: >-
Patient loss-of-function evidence links ALG8 to N-glycosylation via
defective LLO assembly; consistent with other N-glycosylation annotations.
supported_by:
- reference_id: PMID:12480927
supporting_text: "the underlying cause of this new CDG I"
- reference_id: PMID:12480927
supporting_text: "biosynthesis of the dolichyl-linked oligosaccharide"
references:
- id: file:human/ALG8/ALG8-uniprot.txt
title: UniProtKB Q9BVK2 (ALG8_HUMAN)
findings: []
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:12480927
title: A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase
defines a new subtype of congenital disorders of glycosylation.
findings: []
- id: PMID:15235028
title: Clinical and molecular features of three patients with congenital disorders
of glycosylation type Ih (CDG-Ih) (ALG8 deficiency).
findings: []
- id: PMID:25910212
title: Widespread macromolecular interaction perturbations in human genetic disorders.
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
- id: Reactome:R-HSA-446189
title: Addition of a second glucose to the N-glycan precursor by ALG8
findings: []
- id: Reactome:R-HSA-446193
title: Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide,
LLO) and transfer to a nascent protein
findings: []
- id: Reactome:R-HSA-4724330
title: Defective ALG8 does not add glucose to the N-glycan precursor
findings: []
core_functions:
- description: >-
ER-lumenal, Dol-P-Glc-dependent alpha-1,3-glucosyltransferase (EC 2.4.1.265)
that transfers the second glucose from dolichyl-phosphate-glucose onto
Glc1Man9GlcNAc2-PP-dolichol to give Glc2Man9GlcNAc2-PP-dolichol during
lipid-linked oligosaccharide (LLO) assembly.
molecular_function:
id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
directly_involved_in:
- id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
- id: GO:0098553
label: lumenal side of endoplasmic reticulum membrane
supported_by:
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "adds the second glucose residue from dolichyl phosphate glucose"
- reference_id: PMID:12480927
supporting_text: "which catalyzes this reaction"
- description: >-
Through assembly of the mature Glc3Man9GlcNAc2 lipid-linked oligosaccharide
precursor that is transferred en bloc to nascent polypeptides, ALG8 is
required for protein N-linked glycosylation; its loss causes CDG-Ih.
molecular_function:
id: GO:0042283
label: dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
directly_involved_in:
- id: GO:0006487
label: protein N-linked glycosylation
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:12480927
supporting_text: "biosynthesis of the dolichyl-linked oligosaccharide"
- reference_id: file:human/ALG8/ALG8-uniprot.txt
supporting_text: "the glycan precursors employed in\nCC protein asparagine (N)-glycosylation"